[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500777":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":30,"locations":39,"responsibleParty":281,"collaborators":35,"id":283,"slug":284,"hasResults":285,"nctId":286,"briefTitle":287,"officialTitle":288,"acronym":35,"eligibilityCriteria":289,"healthyVolunteers":285,"sex":290,"minAge":291,"maxAge":35,"enrollmentInfo":292,"targetDuration":35,"studyType":295,"phases":296,"briefSummary":298,"conditions":299,"keywords":302,"overallStatus":42,"whyStopped":35,"lastUpdateSubmitDate":304,"lastUpdatePostDateStruct":305,"startDateStruct":308,"completionDateStruct":310,"leadSponsor":312,"locationsCount":313},{"fullName":5,"class":6},"Genentech, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Stage 1: Dose Escalation","EXPERIMENTAL","Participants will receive RO7656594 administered at a specified dose on specific days in each 28-day cycle. The dose will be increased in successive cohorts until a study-specific threshold is reached.",[13],"Drug: RO7656594",{"label":15,"type":10,"description":16,"interventionNames":17},"Stage 2: Expansion","Participants will receive RO7656594 at or below the maximum tolerated dose (MTD) or maximum administered dose (MAD).",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","RO7656594","RO7656594 will be administered orally at specified dose on specified days.",[9,15],[25],"GDC-2992",[27],{"name":28,"affiliation":5,"role":29},"Clinical Trials","STUDY_DIRECTOR",[31,37],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"GO44537 https:\u002F\u002Fforpatients.roche.com\u002F","CONTACT","888-662-6728 (U.S. Only)",null,"global-roche-genentech-trials@gene.com",{"name":38,"role":33,"phone":35,"phoneExt":35,"email":35},"Fastest response: use the inquiry form. No email attachments. https:\u002F\u002Fwww.gene.com\u002Fcontact-us\u002Fsubmit-medical-inquiry",[40,54,64,74,84,94,106,109,119,128,140,150,161,170,179,189,195,201,207,219,228,237,243,254,263,272],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":35},"HonorHealth","RECRUITING","Scottsdale","Arizona","85258","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-111.89903,33.50921,{"lat":52,"lon":51},{"facility":55,"status":42,"city":56,"state":57,"zip":58,"country":46,"countryCode":47,"cosmosGeoPoint":59,"geoPoint":63,"contacts":35},"Yale Cancer Center","New Haven","Connecticut","06510",{"type":49,"coordinates":60},[61,62],-72.92816,41.30815,{"lat":62,"lon":61},{"facility":65,"status":42,"city":66,"state":67,"zip":68,"country":46,"countryCode":47,"cosmosGeoPoint":69,"geoPoint":73,"contacts":35},"Sarah Cannon Research Institute @ Florida Cancer","Orlando","Florida","32827",{"type":49,"coordinates":70},[71,72],-81.37924,28.53834,{"lat":72,"lon":71},{"facility":75,"status":42,"city":76,"state":77,"zip":78,"country":46,"countryCode":47,"cosmosGeoPoint":79,"geoPoint":83,"contacts":35},"University of Illinois Hospital & Health Sciences System","Chicago","Illinois","60612",{"type":49,"coordinates":80},[81,82],-87.65005,41.85003,{"lat":82,"lon":81},{"facility":85,"status":42,"city":86,"state":87,"zip":88,"country":46,"countryCode":47,"cosmosGeoPoint":89,"geoPoint":93,"contacts":35},"SCRI Oncology Partners","Nashville","Texas","37203",{"type":49,"coordinates":90},[91,92],-96.65278,30.82583,{"lat":92,"lon":91},{"facility":95,"status":42,"city":96,"state":97,"zip":98,"country":99,"countryCode":100,"cosmosGeoPoint":101,"geoPoint":105,"contacts":35},"St Vincent's Hospital Sydney","Darlinghurst","New South Wales","2010","Australia","AU",{"type":49,"coordinates":102},[103,104],151.21925,-33.87939,{"lat":104,"lon":103},{"facility":107,"status":42,"city":97,"state":97,"zip":108,"country":99,"countryCode":100,"cosmosGeoPoint":35,"geoPoint":35,"contacts":35},"Macquarie University Hospital","2162",{"facility":110,"status":42,"city":111,"state":112,"zip":113,"country":99,"countryCode":100,"cosmosGeoPoint":114,"geoPoint":118,"contacts":35},"Monash Health Monash Medical Centre","Clayton","Victoria","3168",{"type":49,"coordinates":115},[116,117],145.11667,-37.91667,{"lat":117,"lon":116},{"facility":120,"status":42,"city":121,"state":112,"zip":122,"country":99,"countryCode":100,"cosmosGeoPoint":123,"geoPoint":127,"contacts":35},"Austin Hospital","Heidelberg","3084",{"type":49,"coordinates":124},[125,126],145.06667,-37.75,{"lat":126,"lon":125},{"facility":129,"status":42,"city":130,"state":131,"zip":132,"country":133,"countryCode":134,"cosmosGeoPoint":135,"geoPoint":139,"contacts":35},"British Columbia Cancer Agency","Vancouver","British Columbia","V5Z 4E6","Canada","CA",{"type":49,"coordinates":136},[137,138],-123.11934,49.24966,{"lat":138,"lon":137},{"facility":141,"status":42,"city":142,"state":143,"zip":144,"country":133,"countryCode":134,"cosmosGeoPoint":145,"geoPoint":149,"contacts":35},"Princess Margaret Hospital","Toronto","Ontario","M5G 2M9",{"type":49,"coordinates":146},[147,148],-79.39864,43.70643,{"lat":148,"lon":147},{"facility":151,"status":42,"city":152,"state":35,"zip":153,"country":154,"countryCode":155,"cosmosGeoPoint":156,"geoPoint":160,"contacts":35},"Centre Léon Bérard","Lyon","69008","France","FR",{"type":49,"coordinates":157},[158,159],4.84789,45.74906,{"lat":159,"lon":158},{"facility":162,"status":42,"city":163,"state":35,"zip":164,"country":154,"countryCode":155,"cosmosGeoPoint":165,"geoPoint":169,"contacts":35},"Institut Paoli Calmettes","Marseille","13009",{"type":49,"coordinates":166},[167,168],5.38107,43.29695,{"lat":168,"lon":167},{"facility":171,"status":42,"city":172,"state":35,"zip":173,"country":154,"countryCode":155,"cosmosGeoPoint":174,"geoPoint":178,"contacts":35},"Institut Gustave Roussy","Villejuif","94805",{"type":49,"coordinates":175},[176,177],2.35992,48.7939,{"lat":177,"lon":176},{"facility":180,"status":42,"city":181,"state":35,"zip":182,"country":183,"countryCode":35,"cosmosGeoPoint":184,"geoPoint":188,"contacts":35},"Seoul National University Hospital","Seoul","03080","South Korea",{"type":49,"coordinates":185},[186,187],126.9784,37.566,{"lat":187,"lon":186},{"facility":190,"status":42,"city":181,"state":35,"zip":191,"country":183,"countryCode":35,"cosmosGeoPoint":192,"geoPoint":194,"contacts":35},"Severance Hospital Yonsei University Health System - PPDS","03722",{"type":49,"coordinates":193},[186,187],{"lat":187,"lon":186},{"facility":196,"status":42,"city":181,"state":35,"zip":197,"country":183,"countryCode":35,"cosmosGeoPoint":198,"geoPoint":200,"contacts":35},"Asan Medical Center - PPDS","05505",{"type":49,"coordinates":199},[186,187],{"lat":187,"lon":186},{"facility":202,"status":42,"city":181,"state":35,"zip":203,"country":183,"countryCode":35,"cosmosGeoPoint":204,"geoPoint":206,"contacts":35},"Samsung Medical Center - PPDS","06351",{"type":49,"coordinates":205},[186,187],{"lat":187,"lon":186},{"facility":208,"status":42,"city":209,"state":210,"zip":211,"country":212,"countryCode":213,"cosmosGeoPoint":214,"geoPoint":218,"contacts":35},"Clinica Universidad de Navarra","Pamplona","Navarre","31008","Spain","ES",{"type":49,"coordinates":215},[216,217],-1.64323,42.81687,{"lat":217,"lon":216},{"facility":220,"status":42,"city":221,"state":35,"zip":222,"country":212,"countryCode":213,"cosmosGeoPoint":223,"geoPoint":227,"contacts":35},"Hospital Universitario Vall d'Hebron - PPDS","Barcelona","08035",{"type":49,"coordinates":224},[225,226],2.15899,41.38879,{"lat":226,"lon":225},{"facility":229,"status":42,"city":230,"state":35,"zip":231,"country":212,"countryCode":213,"cosmosGeoPoint":232,"geoPoint":236,"contacts":35},"Clinica Universidad de Navarra-Madrid","Madrid","28027",{"type":49,"coordinates":233},[234,235],-3.70256,40.4165,{"lat":235,"lon":234},{"facility":238,"status":42,"city":230,"state":35,"zip":239,"country":212,"countryCode":213,"cosmosGeoPoint":240,"geoPoint":242,"contacts":35},"Hospital Clinico San Carlos","28040",{"type":49,"coordinates":241},[234,235],{"lat":235,"lon":234},{"facility":244,"status":42,"city":245,"state":35,"zip":246,"country":247,"countryCode":248,"cosmosGeoPoint":249,"geoPoint":253,"contacts":35},"Cambridge Clinical Research Centre","Cambridge","CB2 0AU","United Kingdom","UK",{"type":49,"coordinates":250},[251,252],0.11667,52.2,{"lat":252,"lon":251},{"facility":255,"status":42,"city":256,"state":35,"zip":257,"country":247,"countryCode":248,"cosmosGeoPoint":258,"geoPoint":262,"contacts":35},"Leicester Royal Infirmary","Leicester","LE1 5WW",{"type":49,"coordinates":259},[260,261],-1.13169,52.6386,{"lat":261,"lon":260},{"facility":264,"status":42,"city":265,"state":35,"zip":266,"country":247,"countryCode":248,"cosmosGeoPoint":267,"geoPoint":271,"contacts":35},"The Christie","Manchester","M20 4BX",{"type":49,"coordinates":268},[269,270],-2.23743,53.48095,{"lat":270,"lon":269},{"facility":273,"status":42,"city":274,"state":35,"zip":275,"country":247,"countryCode":248,"cosmosGeoPoint":276,"geoPoint":280,"contacts":35},"Royal Marsden Hospital - Surrey","Sutton","SM2 5PT",{"type":49,"coordinates":277},[278,279],-0.2,51.35,{"lat":279,"lon":278},{"type":282,"investigatorFullName":35,"investigatorTitle":35,"investigatorAffiliation":35,"oldNameTitle":35,"oldOrganization":35},"SPONSOR","100500777","phase-1-a-study-evaluating-the-safety-pharmacokinetics-and-activity-of-ro7656594-in-participants-with-advanced-or-metastatic-prostate-cancer-100500777",false,"NCT05800665","A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer","A Phase 1, Open-Label, Multicenter, Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 in Patients With Advanced or Metastatic Prostate Cancer","Key Inclusion Criteria:\n\n1. Eastern Cooperative Oncology Group (ECOG) performance status ≤1.\n2. Metastatic prostate adenocarcinoma without small-cell carcinoma or neuroendocrine features.\n3. Prior therapy with a second-generation androgen receptor (AR)-targeted therapy (e.g., abiraterone, enzalutamide, apalutamide, darolutamide).\n4. Prior therapy with a taxane regimen or are considered ineligible for treatment with a taxane regimen or have refused treatment with a taxane regimen, unless otherwise specified.\n5. For participants with a known pathogenic breast cancer gene 1 (BRCA1) or BRCA2 mutation: prior therapy with a poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitor, or are considered ineligible for treatment with a PARP inhibitor, if such therapy is approved and available.\n\nKey Exclusion Criteria:\n\n1. Treatment with any approved systemic anti-cancer therapy within 14 days or 5 drug elimination half-lives (whichever is longer, not to exceed 28 days) prior to the first study treatment.\n2. Treatment with any investigational agent within 28 days prior to the first study treatment.\n3. Treatment with any previous AR protein degrader.\n4. Untreated central nervous system (CNS) metastases or leptomeningeal disease.\n\nNote: Other protocol specified inclusion\u002Fexclusion criteria may apply.","MALE","18 Years",{"count":293,"type":294},210,"ESTIMATED","INTERVENTIONAL",[297],"PHASE1","The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regimens for RO7656594 for subsequent studies.",[300,301],"Advanced Prostate Cancer","Metastatic Prostate Cancer",[303],"Castration-resistant","2026-06-11",{"date":306,"type":307},"2026-06-15","ACTUAL",{"date":309,"type":307},"2023-05-02",{"date":311,"type":294},"2027-06-30",{"name":5,"class":6},26]